ArticleAnnals of gastroenterological surgery2023

Efficacy and safety of neoadjuvant nab-paclitaxel plus gemcitabine therapy in patients with borderline resectable pancreatic cancer: A multicenter single-arm phase II study (NAC-GA trial).

Ken-Ichi Okada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.